Tessera Therapeutics
MA - Somerville
Biotechnology4 H-1B visas (FY2023)Focus: Gene Writing
Tessera Therapeutics is a life sciences company focused on Gene Writing.
Rare DiseasesGene Therapy
Open Jobs
2
Pipeline & Clinical Trials
Phase 1/2
Clinical Trials (1)
NCT07227207A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
Phase 1/2Open Jobs (2)
Interview Prep Quick Facts
Portfolio: 1 clinical trial
H-1B (2023): 4 approvals
Open Roles: 2 active jobs
Hiring Trend
Stable
2
Open Roles
+0
Added
-2
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
4
Approved
1
Denied
80%
Rate
Source: USCIS H-1B Employer Data Hub